Advertisement
ResearchIn-Press PreviewCell biologyGenetics
Open Access | 10.1172/JCI187323
1Department of Human Genetics, Biozentrum, University of Würzburg, Würzburg, Germany
2Laboratory of Genetics and Genomics, National Institute on Aging, NIH, Baltimore, United States of America
3Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, United States of America
4Genomics Core and Cancer Genomics Unit, Cancer Genetics and Comparative Gen, National Human Genome Research Institute, NIH, Bethesda, United States of America
Find articles by Kuehl, J. in: JCI | PubMed | Google Scholar
1Department of Human Genetics, Biozentrum, University of Würzburg, Würzburg, Germany
2Laboratory of Genetics and Genomics, National Institute on Aging, NIH, Baltimore, United States of America
3Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, United States of America
4Genomics Core and Cancer Genomics Unit, Cancer Genetics and Comparative Gen, National Human Genome Research Institute, NIH, Bethesda, United States of America
Find articles by Xue, Y. in: JCI | PubMed | Google Scholar
1Department of Human Genetics, Biozentrum, University of Würzburg, Würzburg, Germany
2Laboratory of Genetics and Genomics, National Institute on Aging, NIH, Baltimore, United States of America
3Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, United States of America
4Genomics Core and Cancer Genomics Unit, Cancer Genetics and Comparative Gen, National Human Genome Research Institute, NIH, Bethesda, United States of America
Find articles by Yuan, F. in: JCI | PubMed | Google Scholar
1Department of Human Genetics, Biozentrum, University of Würzburg, Würzburg, Germany
2Laboratory of Genetics and Genomics, National Institute on Aging, NIH, Baltimore, United States of America
3Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, United States of America
4Genomics Core and Cancer Genomics Unit, Cancer Genetics and Comparative Gen, National Human Genome Research Institute, NIH, Bethesda, United States of America
Find articles by Ramanagoudr-Bhojappa, R. in: JCI | PubMed | Google Scholar
1Department of Human Genetics, Biozentrum, University of Würzburg, Würzburg, Germany
2Laboratory of Genetics and Genomics, National Institute on Aging, NIH, Baltimore, United States of America
3Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, United States of America
4Genomics Core and Cancer Genomics Unit, Cancer Genetics and Comparative Gen, National Human Genome Research Institute, NIH, Bethesda, United States of America
Find articles by Pickel, S. in: JCI | PubMed | Google Scholar
1Department of Human Genetics, Biozentrum, University of Würzburg, Würzburg, Germany
2Laboratory of Genetics and Genomics, National Institute on Aging, NIH, Baltimore, United States of America
3Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, United States of America
4Genomics Core and Cancer Genomics Unit, Cancer Genetics and Comparative Gen, National Human Genome Research Institute, NIH, Bethesda, United States of America
Find articles by Kalb, R. in: JCI | PubMed | Google Scholar
1Department of Human Genetics, Biozentrum, University of Würzburg, Würzburg, Germany
2Laboratory of Genetics and Genomics, National Institute on Aging, NIH, Baltimore, United States of America
3Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, United States of America
4Genomics Core and Cancer Genomics Unit, Cancer Genetics and Comparative Gen, National Human Genome Research Institute, NIH, Bethesda, United States of America
Find articles by Chandrasekharappa, S. in: JCI | PubMed | Google Scholar
1Department of Human Genetics, Biozentrum, University of Würzburg, Würzburg, Germany
2Laboratory of Genetics and Genomics, National Institute on Aging, NIH, Baltimore, United States of America
3Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, United States of America
4Genomics Core and Cancer Genomics Unit, Cancer Genetics and Comparative Gen, National Human Genome Research Institute, NIH, Bethesda, United States of America
Find articles by Wang, W. in: JCI | PubMed | Google Scholar
1Department of Human Genetics, Biozentrum, University of Würzburg, Würzburg, Germany
2Laboratory of Genetics and Genomics, National Institute on Aging, NIH, Baltimore, United States of America
3Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, United States of America
4Genomics Core and Cancer Genomics Unit, Cancer Genetics and Comparative Gen, National Human Genome Research Institute, NIH, Bethesda, United States of America
Find articles by Zhang, Y. in: JCI | PubMed | Google Scholar
1Department of Human Genetics, Biozentrum, University of Würzburg, Würzburg, Germany
2Laboratory of Genetics and Genomics, National Institute on Aging, NIH, Baltimore, United States of America
3Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, United States of America
4Genomics Core and Cancer Genomics Unit, Cancer Genetics and Comparative Gen, National Human Genome Research Institute, NIH, Bethesda, United States of America
Find articles by Schindler, D. in: JCI | PubMed | Google Scholar
Published April 15, 2025 - More info
The Fanconi anemia (FA)/BRCA DNA repair network promotes the removal of DNA interstrand crosslinks (ICLs) to counteract their devastating consequences, including oncogenesis. Network signaling is initiated by the FA core complex, which consists of seven authentic FA proteins and an FA-associated protein, FAAP100, with incompletely characterized roles and unknown disease associations. Upon activation, the FA core complex functions as a multiprotein E3 ubiquitin ligase centered on its catalytic module, the FANCB-FANCL-FAAP100 (BLP100) subcomplex, for FANCD2 and FANCI monoubiquitylation. Here, we identified a homozygous variant in FAAP100, c.1642A>C, predicting p.(T542P), in a fetus with malformations suggestive of FA. The mutation causes sensitivity to ICL-inducing agents in cells from the affected individual and genetically engineered, FAAP100-inactivated human, avian, zebrafish, and mouse cells. All FAAP100-deficient cell types were rescued by ectopic expression of wild-type FAAP100, but not FAAP100T542P. In a confirmatory animal model, customized Faap100–/– mice exhibit embryonic lethality, microsomia, malformations, and gonadal atrophy resembling mice with established FA subtypes. Mechanistically, FAAP100T542P impairs ligase activity by preventing BLP100 subcomplex formation, resulting in defective FAAP100T542P nuclear translocation and chromatin recruitment. FAAP100 dysfunction that disrupts the FA pathway and impairs genomic maintenance, together with FAconsistent human manifestations, recommends FAAP100 as a legitimate FA gene, FANCX.